Search
All
MaaT Pharma announced today that it treated its first patient in a Phase 1 clinical trial to evaluate the safety and tolerability of MaaT033, a capsule formulation of the...
A consumer dermatology company developing novel, personalized, microbiome-based solutions for acne and other skin conditions, announced today that it has closed a $6.73 million...
BiomX Inc. (NYSE American: PHGE), a clinical stage company developing natural and engineered phage therapies that target specific pathogenic bacteria, today announced that the...
Animab, a venture spin-off from VIB, announces today that it has successfully concluded a 3.4 M€ seed financing round. The company develops monoclonal antibodies for oral...
In the video lectures, Amy Sussman explains which patients are most at risk for renal disease, ways to prevent it, and how to diagnose it early.
Following the announcement on July 31, 2020 of the entry into exclusive negotiations between ATEME and the main shareholders of Anevia and the completion, by these latest, of...
This category recognises the most impactful & innovative financial products and services operating globally across numerous areas, including Retail & Payments, Banking, Fraud &...
Federation Bio, a microbial therapeutics company targeting diseases in which the human microbiome can play a curative role, today announced that it has closed a $50 million...
LARQ was started with a simple vision where innovative technology can be combined with inspirational design to help people access pristine drinking water easily and...
